GlassScriptPhysician profile
Sean Joseph Langenfeld
NPI 1396967899
$1,677.11
in general payments reported to CMS, 2019-2025
11 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2021: $125 · 2022: $228 · 2023: $216 · 2024: $462 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $449.50 | 2019-2023 | Airseal |
| Thd America, INC. | $348.76 | 2024-2025 | |
| Stryker Corporation | $167.86 | 2025 | Sonopet Iq, Spy-Phi System, 1788 |
| Virtual Incision Corporation | $154.00 | 2024 | Mira |
| Intuitive Surgical, INC. | $137.64 | 2024 | |
| Guard Medical INC. | $127.43 | 2022 | |
| Integra Lifesciences Corporation | $100.49 | 2022 | |
| Dilon Technologies, INC. | $62.50 | 2025 | Hemoblast Bellows |
| Vertex Pharmaceuticals Incorporated | $60.00 | 2025 | |
| Karl Storz Endoscopy-America | $35.99 | 2023 | |
| Davol INC. | $32.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Langenfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.